The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway
Authors
Keywords
Prostate cancer, Castration-resistant, WNT signaling pathway, Endoplasmic reticulum stress
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-06
DOI
10.1186/s13046-019-1342-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Wnt signalling in advanced prostate cancer
- (2018) Imran Ahmad et al. JOURNAL OF PATHOLOGY
- Revisiting the role of Wnt/β-catenin signaling in prostate cancer
- (2018) Jeffrey A. Schneider et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Unfolded Protein Response: A Novel Therapeutic Target for Poor PrognosticBRAFMutant Colorectal Cancer
- (2018) Nicholas Forsythe et al. MOLECULAR CANCER THERAPEUTICS
- WNT signalling in prostate cancer
- (2017) Virginia Murillo-Garzón et al. Nature Reviews Urology
- Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics
- (2017) Roya Tabatabai et al. Targeted Oncology
- Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma
- (2016) Yves-Paul Vandewynckel et al. BMC CANCER
- Carfilzomib Triggers Cell Death in Chronic Lymphocytic Leukemia by Inducing Proapoptotic and Endoplasmic Reticulum Stress Responses
- (2016) B. Lamothe et al. CLINICAL CANCER RESEARCH
- Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression
- (2016) Tyler M. Bauman et al. HUMAN PATHOLOGY
- Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015
- (2016) William T. Lowrance et al. JOURNAL OF UROLOGY
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- Controlling the unfolded protein response-mediated life and death decisions in cancer
- (2015) Marion Maurel et al. SEMINARS IN CANCER BIOLOGY
- Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer
- (2015) Jing Li et al. TUMOR BIOLOGY
- Endoplasmic Reticulum Stress-Activated Cell Reprogramming in Oncogenesis
- (2015) E. Chevet et al. Cancer Discovery
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endoplasmic Reticulum Stress and the Unfolded Protein Response: Targeting the Achilles Heel of Multiple Myeloma
- (2013) L. Vincenz et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of androgen receptor and -catenin activity in prostate cancer
- (2013) E. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Activation of -Catenin Signaling in Androgen Receptor-Negative Prostate Cancer Cells
- (2012) X. Wan et al. CLINICAL CANCER RESEARCH
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies
- (2012) B Luo et al. ONCOGENE
- Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
- (2011) Ira Tabas et al. NATURE CELL BIOLOGY
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
- (2010) F. Takahashi-Yanaga et al. CLINICAL CANCER RESEARCH
- Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
- (2009) T Noda et al. BRITISH JOURNAL OF CANCER
- The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
- (2009) M Flahaut et al. ONCOGENE
- The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens
- (2008) Liang Schweizer et al. BMC CELL BIOLOGY
- Crosstalk between the Androgen Receptor and -Catenin in Castrate-Resistant Prostate Cancer
- (2008) G. Wang et al. CANCER RESEARCH
- Tumor Hypoxia Blocks Wnt Processing and Secretion through the Induction of Endoplasmic Reticulum Stress
- (2008) M. Verras et al. MOLECULAR AND CELLULAR BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started